Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1977 Dec;30(3):338–346.

Protective activity of secondary effector T cells generated in vitro against ectromelia virus infection in vivo.

U Kees, R V Blanden
PMCID: PMC1541155  PMID: 203425

Abstract

The anti-viral activity of secondary effector cells generated in vitro against ectromelia virus infection was investigated. Depending upon the order of administration of cells and virus, 2 X 10(6) cells significantly reduce virus titres in recipient mice. Mice injected with lymphocytic choriomeningitis (LCM) virus are not protected by secondary effector cells against ectromelia virus infection and vice versa. The cells conferring anti-viral activity are sensitive to anti-theta and complement treatment, and must share H-2K or H-2D region genes with the recipients in order for significant reduction of virus titres to occur. The possibility of exploiting this approach in clinical medicine by using T cell-mediated mechanisms against certain viral infections is briefly discussed.

Full text

PDF
338

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blanden R. V., Bowern N. A., Pang T. E., Gardner I. D., Parish C. R. Effects of thymus-independent (B) cells and the H-2 gene complex on antiviral function of immune thymus-derived (T) cells. Aust J Exp Biol Med Sci. 1975 Jun;53(3):187–195. doi: 10.1038/icb.1975.19. [DOI] [PubMed] [Google Scholar]
  2. Blanden R. V., Doherty P. C., Dunlop M. B., Gardner I. D., Zinkernagel R. M., David C. S. Genes required for cytotoxicity against virus-infected target cells in K and D regions of H-2 complex. Nature. 1975 Mar 20;254(5497):269–270. doi: 10.1038/254269a0. [DOI] [PubMed] [Google Scholar]
  3. Blanden R. V., Gardner I. D. The cell-mediated immune response to ectromelia virus infection. I. Kinetics and characteristics of the primary effector T cell response in vivo. Cell Immunol. 1976 Mar 15;22(2):271–282. doi: 10.1016/0008-8749(76)90029-0. [DOI] [PubMed] [Google Scholar]
  4. Blanden R. V., Kees U., Dunlop M. B. In vitro primary induction of cytotoxic T cells against virus-infected syngeneic cells. J Immunol Methods. 1977;16(1):73–89. doi: 10.1016/0022-1759(77)90040-0. [DOI] [PubMed] [Google Scholar]
  5. Blanden R. V. Mechanisms of recovery from a generalized viral infection: mousepox. 3. Regression infectious foci. J Exp Med. 1971 May 1;133(5):1090–1104. doi: 10.1084/jem.133.5.1090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Blanden R. V. Mechanisms of recovery from a generalized viral infection: mousepox. I. The effects of anti-thymocyte serum. J Exp Med. 1970 Nov;132(5):1035–1054. doi: 10.1084/jem.132.5.1035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Blanden R. V. Mechanisms of recovery from a generalized viral infection: mousepox. II. Passive transfer of recovery mechanisms with immune lymphoid cells. J Exp Med. 1971 May 1;133(5):1074–1089. doi: 10.1084/jem.133.5.1074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Davidson W. F., Parish C. R. A procedure for removing red cells and dead cells from lymphoid cell suspensions. J Immunol Methods. 1975 Jun;7(2-3):291–300. doi: 10.1016/0022-1759(75)90026-5. [DOI] [PubMed] [Google Scholar]
  9. Dunlop M. B., Blanden R. V. Secondary cytotoxic cell response to lymphocytic choriomeningitis virus. I. Kinetics of induction in vitro and yields of effector cells. Immunology. 1976 Aug;31(2):171–180. [PMC free article] [PubMed] [Google Scholar]
  10. Gardner I. D., Blanden R. V. The cell-mediated immune response to ectromelia virus infection. II. Secondary response in vitro and kinetics of memory T cell production in vivo. Cell Immunol. 1976 Mar 15;22(2):283–296. doi: 10.1016/0008-8749(76)90030-7. [DOI] [PubMed] [Google Scholar]
  11. Gardner I., Bowern N. A., Blanden R. V. Cell-mediated cytotoxicity against ectromelia virus-infected target cells. I. Specificity and kinetics. Eur J Immunol. 1974 Feb;4(2):63–67. doi: 10.1002/eji.1830040202. [DOI] [PubMed] [Google Scholar]
  12. Gardner I., Bowern N. A., Blanden R. V. Cell-mediated cytotoxicity against ectromelia virus-infected target cells. II. Identification of effector cells and analysis of mechanisms. Eur J Immunol. 1974 Feb;4(2):68–72. doi: 10.1002/eji.1830040203. [DOI] [PubMed] [Google Scholar]
  13. Kees U., Blanden R. V. A single genetic element in H-2K affects mouse T-cell antiviral function in poxvirus infection. J Exp Med. 1976 Feb 1;143(2):450–455. doi: 10.1084/jem.143.2.450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Pang T., Blanden R. V. Genetic factors in the stimulation of T cell responses against ectromelia virus-infected cells: role of H-2K, H-2D, and H-2I genes. Aust J Exp Biol Med Sci. 1977 Oct;55(5):549–559. doi: 10.1038/icb.1977.54. [DOI] [PubMed] [Google Scholar]
  15. Pang T., Blanden R. V. Regulation of the T-cell response to ectromelia virus infection. I. Feedback suppression by effector T cells. J Exp Med. 1976 Mar 1;143(3):469–481. doi: 10.1084/jem.143.3.469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Pang T., Blanden R. V. The cell-mediated immune response to ectromelia virus infection. Secondary response in vitro: specificity, nature of effector and responder cells and requirements for induction of antigenic changes in stimulator cells. Aust J Exp Biol Med Sci. 1976 Jun;54(3):253–264. [PubMed] [Google Scholar]
  17. Zinkernagel R. M., Doherty P. C. Characteristics of the interaction in vitro between cytotoxic thymus-derived lymphocytes and target monolayers infected with lymphocytic choriomeningitis virus. Scand J Immunol. 1974;3(3):287–294. doi: 10.1111/j.1365-3083.1974.tb01259.x. [DOI] [PubMed] [Google Scholar]
  18. Zinkernagel R. M., Doherty P. C. Peritoneal macrophages as target cells for measuring virus-specific T cell mediated cytotoxicity in vitro. J Immunol Methods. 1975 Sep;8(3):263–266. doi: 10.1016/0022-1759(75)90120-9. [DOI] [PubMed] [Google Scholar]
  19. Zinkernagel R. M., Pang T., Blanden R. V. Effect of cell dose and dose of infectious agent on expression of protection against Listeria monocytogenes and Ectromelia virus in cell transfer models. Infect Immun. 1975 Jun;11(6):1170–1173. doi: 10.1128/iai.11.6.1170-1173.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES